Page last updated: 2024-08-16

temozolomide and gsk525762a

temozolomide has been researched along with gsk525762a in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, C; He, X; Hua, X; Kong, X; Liu, X; Matkar, S; Wang, L; Xie, G1

Other Studies

1 other study(ies) available for temozolomide and gsk525762a

ArticleYear
BRD4 inhibitor IBET upregulates p27kip/cip protein stability in neuroendocrine tumor cells.
    Cancer biology & therapy, 2017, 04-03, Volume: 18, Issue:4

    Topics: Antineoplastic Agents; Benzodiazepines; Capecitabine; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Dacarbazine; Drug Resistance, Neoplasm; Epigenesis, Genetic; Humans; Neuroendocrine Tumors; Nuclear Proteins; Octreotide; Protein Stability; RNA, Messenger; S-Phase Kinase-Associated Proteins; Temozolomide; Transcription Factors; Transcriptional Activation; Ubiquitin-Protein Ligases; Ubiquitination; Up-Regulation

2017